The Motley Fool Discussion Boards

Previous Page

International Investing / Australia (All-Ordinaries)


Subject:  Novogen News Date:  2/7/2000  3:32 AM
Author:  Lems Number:  1092 of 6186

Now that applefoot is on holiday, I will keep you guys informed on our little gem.

Novogen, ASX:NRT, Nasdaq: NVGN was up 33 cent today on the news that its anti-cancer drug NV-06 was approved for phase I clinical testing. Testing will begin immediately.

The news came out only in the afternoon, it will certainly go up some more tomorrow.

Copyright 1996-2022 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us